Synageva BioPharma Corp (NASDAQ:GEVA)

During the Trading Day
103.20 +1.96 / +1.94%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
103.20 0.00 / 0.00%
 
Volume: 7.4K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues2.1M15.0M13.4M6.5M
 
 
 
 
 
Depreciation And Amortization999.8K4.3M5.6M--
 
 
 
 
 
Operating ExpensesGross Income1.1M------
 
 
General Expenses26.1M53.7M101.2M197.1M
 
 
 
 
 
Other Operating Expenses0.000.000.001.5M
 
 
Research And Development17.8M37.3M73.7M142.6M
 
 
 
 
 
Total Operating Expenses27.1M58.0M106.8M198.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-25.0M-43.0M-93.4M-192.1M
 
 
 
 
 
Extraordinary Charge0.000.00-2.5M--
 
 
Interest Expense On Debt33.5K0.000.00--
 
 
Other Expenses-258.5K0.00159.0K-238.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-25.3M-42.9M-95.4M-192.1M
 
 
 
 
 
Income Taxes0.000.00-48.0K-540.0K
 
 
 
Net Income-25.3M-42.9M-95.5M-192.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.0M22.6M28.1M32.7M
 
 
 
 
 
Shares To Calculate EPS Diluted3.0M22.6M28.1M32.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$8.58-$1.90-$3.40-$5.89
 
 
 
 
 
EPS Diluted-$8.58-$1.90-$3.40-$5.89
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account